Christensen Jamie's Form 4 filing
Mirati Therapeutics, Inc. (MRTX) · filed Sep 12, 2023
- Accession no.
- 0001628280-23-032116
- Filed
- Sep 12, 2023
- Trade date
- Sep 8, 2023
- Filing delay
- 4 days
- Rule 10b5-1 plan
- Not checked
This filing lists 1 non-derivative transaction and 0 derivative transactions. Open-market sales total $85.1K. It was filed 4 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Christensen JamieCIK 0001599324 | Officer (EVP & Chief Scientific Officer) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Sep 8, 2023 | Common Stock | SSaleDisposed | −2,388 | $35.63 | −$85,084.44 | 144,032 | Direct |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.